Trexquant Investment’s RAPT Therapeutics RAPT Stock Holding History

Trexquant Investment’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-54,016	Closed	-$1.83M	–	2006
2025 Q4	$1.83M	Buy	+54,016	New	+$1.68M	0.02%	1019
2024 Q4	–	Sell	-4,744	Closed	-$76.3K	–	1800
2024 Q3	$76.3K	Sell	4,744 -13,301	-74%	-$269K	﹤0.01%	1482
2024 Q2	$440K	Sell	18,045 -1,660	-8%	-$76.7K	0.01%	1286
2024 Q1	$1.42M	Buy	+19,705	New	+$2.74M	0.03%	781
2021 Q3	–	Sell	-1,780	Closed	-$453K	–	1421
2021 Q2	$453K	Buy	+1,780	New	+$333K	0.04%	538

Trexquant Investment's RAPT Position: Q1 2026 in Review

Trexquant Investment sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 54,016 shares — an estimated $1.83M sold.

Trexquant Investment first reported a position in RAPT in Q2 2021 and held it in 5 quarters. The position peaked at $1.83M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Trexquant Investment reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Trexquant Investment sold 54,016 RAPT Therapeutics shares in Q1 2026, an estimated $1.83M.
Trexquant Investment first reported a position in RAPT Therapeutics in Q2 2021 and held it in 5 quarters.
Trexquant Investment's RAPT Therapeutics position peaked at $1.83M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.